Together, Working Toward a Brighter Future for Children with pLGG
Pediatric low-grade gliomas (pLGGs) are the most common brain tumors in children and have a profound and lasting impact on a child’s life. Some children face years of treatment, live with tumors that cannot be safely removed, or experience tumor progression or recurrence. Because these tumors develop in a growing brain, the effects of both the disease and its treatment can extend far beyond the tumor itself.
Established in 2007, the mission of the Dana-Farber Cancer Institute’s pLGG Program is to provide comprehensive, multidisciplinary, and high-quality care with the goal of a cure for every patient. Our program brings together clinician scientists with multidisciplinary expertise working in partnership with patient families, advocates, and community members in pursuit of our mission.
Our vision is to bring together scientists and clinicians with diverse scientific backgrounds and expertise to lead research focused on understanding what makes pediatric gliomas grow, to develop potent and safe therapeutic strategies that are rapidly translated into global clinical trials.
Support PLGG Research
Children diagnosed with low-grade gliomas are too frequently faced with life long effects from the tumors and their treatments.
Our team of research scientists and clinicians is working to identify targetable vulnerabilities in PLGGs, and to develop desperately needed new therapies that attack only cancer cells, leaving healthy cells unharmed.
Your gift will support our research and improve the outlook for pediatric PLGG patients.
